❌

Reading view

DrugRAG: Enhancing Pharmacy LLM Performance Through A Novel Retrieval-Augmented Generation Pipeline

arXiv:2512.14896v1 Announce Type: cross Abstract: Objectives: To evaluate large language model (LLM) performance on pharmacy licensure-style question-answering (QA) tasks and develop an external knowledge integration method to improve their accuracy. Methods: We benchmarked eleven existing LLMs with varying parameter sizes (8 billion to 70+ billion) using a 141-question pharmacy dataset. We measured baseline accuracy for each model without modification. We then developed a three-step retrieval-augmented generation (RAG) pipeline, DrugRAG, that retrieves structured drug knowledge from validated sources and augments model prompts with evidence-based context. This pipeline operates externally to the models, requiring no changes to model architecture or parameters. Results: Baseline accuracy ranged from 46% to 92%, with GPT-5 (92%) and o3 (89%) achieving the highest scores. Models with fewer than 8 billion parameters scored below 50%. DrugRAG improved accuracy across all tested models, with gains ranging from 7 to 21 percentage points (e.g., Gemma 3 27B: 61% to 71%, Llama 3.1 8B: 46% to 67%) on the 141-item benchmark. Conclusion: We demonstrate that external structured drug knowledge integration through DrugRAG measurably improves LLM accuracy on pharmacy tasks without modifying the underlying models. This approach provides a practical pipeline for enhancing pharmacy-focused AI applications with evidence-based information.
  •  

Leveraging LLMs for Structured Data Extraction from Unstructured Patient Records

arXiv:2512.13700v1 Announce Type: new Abstract: Manual chart review remains an extremely time-consuming and resource-intensive component of clinical research, requiring experts to extract often complex information from unstructured electronic health record (EHR) narratives. We present a secure, modular framework for automated structured feature extraction from clinical notes leveraging locally deployed large language models (LLMs) on institutionally approved, Health Insurance Portability and Accountability Act (HIPPA)-compliant compute infrastructure. This system integrates retrieval augmented generation (RAG) and structured response methods of LLMs into a widely deployable and scalable container to provide feature extraction for diverse clinical domains. In evaluation, the framework achieved high accuracy across multiple medical characteristics present in large bodies of patient notes when compared against an expert-annotated dataset and identified several annotation errors missed in manual review. This framework demonstrates the potential of LLM systems to reduce the burden of manual chart review through automated extraction and increase consistency in data capture, accelerating clinical research.
  •  

Enhancing Transparency and Traceability in Healthcare AI: The AI Product Passport

arXiv:2512.13702v1 Announce Type: cross Abstract: Objective: To develop the AI Product Passport, a standards-based framework improving transparency, traceability, and compliance in healthcare AI via lifecycle-based documentation. Materials and Methods: The AI Product Passport was developed within the AI4HF project, focusing on heart failure AI tools. We analyzed regulatory frameworks (EU AI Act, FDA guidelines) and existing standards to design a relational data model capturing metadata across AI lifecycle phases: study definition, dataset preparation, model generation/evaluation, deployment/monitoring, and passport generation. MLOps/ModelOps concepts were integrated for operational relevance. Co-creation involved feedback from AI4HF consortium and a Lisbon workshop with 21 diverse stakeholders, evaluated via Mentimeter polls. The open-source platform was implemented with Python libraries for automated provenance tracking. Results: The AI Product Passport was designed based on existing standards and methods with well-defined lifecycle management and role-based access. Its implementation is a web-based platform with a relational data model supporting auditable documentation. It generates machine- and human-readable reports, customizable for stakeholders. It aligns with FUTURE-AI principles (Fairness, Universality, Traceability, Usability, Robustness, Explainability), ensuring fairness, traceability, and usability. Exported passports detail model purpose, data provenance, performance, and deployment context. GitHub-hosted backend/frontend codebases enhance accessibility. Discussion and Conclusion: The AI Product Passport addresses transparency gaps in healthcare AI, meeting regulatory and ethical demands. Its open-source nature and alignment with standards foster trust and adaptability. Future enhancements include FAIR data principles and FHIR integration for improved interoperability, promoting responsible AI deployment.
  •  

Graph AI generates neurological hypotheses validated in molecular, organoid, and clinical systems

arXiv:2512.13724v1 Announce Type: cross Abstract: Neurological diseases are the leading global cause of disability, yet most lack disease-modifying treatments. We present PROTON, a heterogeneous graph transformer that generates testable hypotheses across molecular, organoid, and clinical systems. To evaluate PROTON, we apply it to Parkinson's disease (PD), bipolar disorder (BD), and Alzheimer's disease (AD). In PD, PROTON linked genetic risk loci to genes essential for dopaminergic neuron survival and predicted pesticides toxic to patient-derived neurons, including the insecticide endosulfan, which ranked within the top 1.29% of predictions. In silico screens performed by PROTON reproduced six genome-wide $\alpha$-synuclein experiments, including a split-ubiquitin yeast two-hybrid system (normalized enrichment score [NES] = 2.30, FDR-adjusted $p
  •  

TF-MCL: Time-frequency Fusion and Multi-domain Cross-Loss for Self-supervised Depression Detection

arXiv:2512.13736v1 Announce Type: cross Abstract: In recent years, there has been a notable increase in the use of supervised detection methods of major depressive disorder (MDD) based on electroencephalogram (EEG) signals. However, the process of labeling MDD remains challenging. As a self-supervised learning method, contrastive learning could address the shortcomings of supervised learning methods, which are unduly reliant on labels in the context of MDD detection. However, existing contrastive learning methods are not specifically designed to characterize the time-frequency distribution of EEG signals, and their capacity to acquire low-semantic data representations is still inadequate for MDD detection tasks. To address the problem of contrastive learning method, we propose a time-frequency fusion and multi-domain cross-loss (TF-MCL) model for MDD detection. TF-MCL generates time-frequency hybrid representations through the use of a fusion mapping head (FMH), which efficiently remaps time-frequency domain information to the fusion domain, and thus can effectively enhance the model's capacity to synthesize time-frequency information. Moreover, by optimizing the multi-domain cross-loss function, the distribution of the representations in the time-frequency domain and the fusion domain is reconstructed, thereby improving the model's capacity to acquire fusion representations. We evaluated the performance of our model on the publicly available datasets MODMA and PRED+CT and show a significant improvement in accuracy, outperforming the existing state-of-the-art (SOTA) method by 5.87% and 9.96%, respectively.
  •  

A data-physics hybrid generative model for patient-specific post-stroke motor rehabilitation using wearable sensor data

arXiv:2512.14329v1 Announce Type: cross Abstract: Dynamic prediction of locomotor capacity after stroke is crucial for tailoring rehabilitation, yet current assessments provide only static impairment scores and do not indicate whether patients can safely perform specific tasks such as slope walking or stair climbing. Here, we develop a data-physics hybrid generative framework that reconstructs an individual stroke survivor's neuromuscular control from a single 20 m level-ground walking trial and predicts task-conditioned locomotion across rehabilitation scenarios. The system combines wearable-sensor kinematics, a proportional-derivative physics controller, a population Healthy Motion Atlas, and goal-conditioned deep reinforcement learning with behaviour cloning and generative adversarial imitation learning to generate physically plausible, patient-specific gait simulations for slopes and stairs. In 11 stroke survivors, the personalized controllers preserved idiosyncratic gait patterns while improving joint-angle and endpoint fidelity by 4.73% and 12.10%, respectively, and reducing training time to 25.56% relative to a physics-only baseline. In a multicentre pilot involving 21 inpatients, clinicians who used our locomotion predictions to guide task selection and difficulty obtained larger gains in Fugl-Meyer lower-extremity scores over 28 days of standard rehabilitation than control clinicians (mean change 6.0 versus 3.7 points). These findings indicate that our generative, task-predictive framework can augment clinical decision-making in post-stroke gait rehabilitation and provide a template for dynamically personalized motor recovery strategies.
  •  

Automated Multitier Tagging of Chinese Online Health Education Resources Using a Large Language Model: Development and Validation Study

Background: Precision health promotion, which aims to tailor health messages to individual needs, is hampered by the lack of structured metadata in vast digital health resource libraries. This bottleneck prevents scalable, personalized content delivery and exacerbates information overload for the public. Objective: This study aimed to develop, deploy, and validate an automated tagging system using a large language model (LLM) to create the foundational metadata infrastructure required for tailored health communication at scale. Methods: We developed a comprehensive, 3-tier health promotion taxonomy (10 primary, 34 secondary, and 90,562 tertiary tags) using a hybrid Delphi and corpus-mining methodology. We then constructed a hybrid inference pipeline by fine-tuning a Baichuan2-7B LLM with low-rank adaptation for initial tag generation. This was then refined by a domain-specific named entity recognition model and standardized against a vector database. The system’s performance was evaluated against manual annotations from nonexpert staff on a test set of 1000 resources. We used a “no gold standard” framework, comparing the artificial intelligence–human (A-H) interrater reliability (IRR) with a supplemental human-human (H-H) IRR baseline and expert adjudication for cases where artificial intelligence provided additional tags (“AI Additive”). Results: The A-H agreement was moderate (Cohen κ=0.54, 95% CI 0.53-0.56; Jaccard similarity coefficient=0.48, 95% CI 0.46-0.50). Critically, this was higher than the baseline nonexpert H-H agreement (Cohen κ=0.32, 95% CI 0.29-0.35; Jaccard similarity coefficient=0.35, 95% CI 0.27-0.43). A granular analysis of disagreements revealed that in 15.9% (159/1000) of the cases, the “AI Additive” tags were not identified by human annotators. Expert adjudication of these cases confirmed that the “AI Additive” tags were correct and relevant with a precision of 90% (45/50; 95% CI 78.2%-96.7%). Conclusions: A fine-tuned LLM, integrated into a hybrid pipeline, can function as a powerful augmentation tool for health content annotation. The system’s consistency (A-H κ=0.54) was found to be superior to the baseline human workflow (H-H κ=0.32). By moving beyond simple automation to reliably identify relevant health topics missed by manual annotators with high, expert-validated accuracy, this study provides a robust technical and methodological blueprint for implementing artificial intelligence to enhance precision health communication in public health settings.
  •  

Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma

Commun Biol. 2025 Dec 16;8(1):1773. doi: 10.1038/s42003-025-09162-w.

ABSTRACT

Pulmonary pleomorphic carcinoma (PPC) is a rare subtype of lung cancer that comprises both epithelial and sarcomatoid components. The molecular basis of PPC, including the cellular dynamics of its components, remains largely unknown. To elucidate potential therapeutic targets for PPC, we perform a multi-omics analysis incorporating digital spatial profiling and single-cell RNA sequencing (scRNA-seq). PPC exhibits diverse driver gene alterations, including MET exon 14 skipping mutation (METex14) and ALK fusion. In spatial transcriptomics, MET gene and protein are overexpressed exclusively within the epithelial component and not in the sarcomatoid component, even in patients harboring METex14. Epithelial-mesenchymal transition (EMT)-related transcriptional changes, along with extracellular matrix (ECM) remodeling between the epithelial and sarcomatoid components, are observed. scRNA-seq identifies cell populations within the epithelial component that contribute to the malignant transformation and differentiation of the sarcomatoid component. They are characterized by an intermediate EMT state with ECM remodeling signature, suggesting their potential as novel therapeutic targets for PPC.

PMID:41402584 | PMC:PMC12708732 | DOI:10.1038/s42003-025-09162-w

  •  
❌